Transgenic mouse models of vasopressin expression

Area of Science:

• Neuroendocrinology
• Molecular Biology
• Genetics

Background:

• Arginine vasopressin (AVP) is a crucial neuropeptide hormone regulating water balance, blood pressure, and stress responses.
• Previous studies utilized whole animal and in vitro models, but lacked in vivo gene regulation insights.
• Existing transgenic mouse models for AVP did not replicate endogenous gene expression patterns.

Purpose of the Study:

• To develop a transgenic mouse model for studying in vivo regulation of the vasopressin gene.
• To assess tissue-specific expression and osmotic regulation of a novel vasopressin gene construct.
• To evaluate the physiological impact of altered vasopressin levels in transgenic mice.

Main Methods:

• Construction and implementation of an 8.2-kb rat vasopressin genomic DNA construct with extensive flanking sequences.
• Generation of transgenic mice carrying the vasopressin gene construct.
• Analysis of transgene expression, mRNA levels, plasma vasopressin peptide, and water metabolism in homozygous transgenic mice.

Main Results:

• The developed transgenic mice exhibit tissue-specific expression of the vasopressin transgene.
• Transgenic animals demonstrate appropriate osmotic regulation of vasopressin mRNA and normal water metabolism.
• Homozygous transgenic mice show elevated basal plasma vasopressin peptide levels without affecting basal water metabolism.

Conclusions:

• This transgenic mouse line accurately reflects tissue-specific and osmotically regulated vasopressin gene expression in vivo.
• The model provides a valuable platform for future investigations into the in vivo regulation of the vasopressin gene.
• Findings contribute to understanding vasopressin's role in physiological processes and gene regulation mechanisms.